12

Mar2021

PDCI Launches Two New Sharing Sites for Policy Submissions: 1. Federal ISED Biomanufacturing Consultation 2. Health Canada National Drugs for Rare Diseases Consultation

Biomanufacturing Consultations - Consultations Open Until March 12 Earlier this year, the Government of Canada invited submissions on the topic of considering the creation of new biomanufacturing capacity for Canadians. Innovation, Science and Economic Development Canada (ISED), in partnership ... Read More

26

Feb2021

Welcome Chris Boodoo and Hussein El-Khechen to the PDCI Team!

PDCI Market Access has further expanded its HTA Team! Chris joins PDCI as a Senior Health Economist. Chris holds a MSc. in Health Services Research from the University of ... Read More

07

Dec2020

PDCI Market Access Joins McKesson Canada

A Message fromKaitlyn Proulx Managing Director, PDCI Market Access I am thrilled to be sharing the news of the recent acquisition of PDCI Market Access by McKesson Canada Corporation. Over the years, PDCI has continued to grow and thrive ... Read More

04

Nov2020

PMPRB Public Webinar DELAYED to November 20, 2020

Last week, the PMPRB announced that they would be hosting a public webinar for all its stakeholders in order to communicate the key elements within the Final Guidelines and to address questions. The webinar was originally scheduled for November 10, 2020 but has been rescheduled to November ... Read More

28

Oct2020

REMINDER: PDCI is Hosting a Webinar on the PMPRB Final Guidelines

PDCI Market Access is hosting a free webinar for pharmaceutical industry members on the final Guidelines released by the PMPRB on October 23rd, 2020. PDCI has released a summary on the key highlights of the final Guidelines and the PDCI ... Read More

30

Sep2020

PDCI Market Access, Connex Health Consulting and H3 Consulting are Pleased to Release the 2020 Private Payer PLA Report!

Over the last few months, PDCI Market Access Inc., Connex Health and H3 Consulting have undertaken an initiative to better understand the Canadian private payer product listing agreement (PLA) landscape and how it has evolved ... Read More

30

Sep2020

PDCI PLA Study Report – PDCI Market Access Inc., Connex Health Consulting, H3 Consulting

PDCI-PLA-Study-Report-PDCI-Market-Access-Inc.-Connex-Health-Consulting-H3-ConsultingDownload

25

Sep2020

Welcome Mevin Mathew, Nicolas Iragorri and Shabna Mohideen to the PDCI Team!

At PDCI Market Access Inc., our vision at PDCI is to be your most trusted and valued pricing and reimbursement strategic partner. To ensure we continue to meet the strategic needs of our customers in the face of the ever-changing Canadian reimbursement landscape, we’ve expanded our Health Economic ... Read More

10

Sep2020

Volume 1 Issue 1 Release of PDCI Market Access Insights Journal

PDCI Market Access is pleased to release our premier issue of PDCI Market Access INSIGHTS online journal to our Market Access Toolkit subscribers. The articles in our first issue provide deep dives into: Planning and budgeting PSPs during the pandemic,New data and new perspectives on private insurers and ... Read More

09

Sep2020

Neil Palmer is Guest Editor, Cell & Gene Therapy Insights Spotlight on Market Access

The August 2020 issue of Cell & Gene Therapy Insights, has a focus on Market access: evolving commercialization trends and strategies.  PDCI Market Access’ very own Neil Palmer is featured as a guest editor and the author of the article, Under construction: roadmaps for HTA, pricing and ... Read More